Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15611490 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Bortezomib in Late Antibody-mediated Kidney Transplant Rejection
Conditions: Late Rejection of Renal Transplant;   Antibody-mediated Rejection
Interventions: Drug: Bortezomib;   Drug: Placebo

Indicates status has not been verified in more than two years